March 20th 2025
The session provides an overview of the uninsured population, and also tackles challenges faced by patients when it comes to accessing PAPs.
March 19th 2025
The conference’s first panel offers insight on the current state of awareness among beneficiaries of the Part D cap and Medicare Prescription Payment Plan via the PAN Foundation’s latest research.
March 18th 2025
The conference’s opening session highlights the sector’s current landscape of healthcare coverage and access.
March 17th 2025
Why having these strategies for results—amid disruptions—will be critical to success.
March 4th 2025
The 25% tax on various imports have gone into effect, resulting in retaliatory tariffs from the impacted nations.
Patient support services: more of them in 2019, but compliance uncertainties persist
Helio Health survey sees nagging compliance problems
The next 10 years of pharma serialization?
Global Track & Trace Forum commemorates its 10th anniversary
Teva does an about-face on manufacturing vincristine, following a public outcry
Change.org touts its influence in the decision
The current state of suspicious- order monitoring
DEA’s manufacturer and distributor data-collection requirements are changing
The modern way to manage commercial data
Sample management is just one of many focus areas for sales operations
HHS sues Gilead for patent infringement over PrEP
Licensing for Gilead’s Truvada and Descovy products is in question
Stericycle unloads its reverse-distribution business to Pharma Logistics
Action expands Pharma Logistics’ leadership in servicing independent pharmacies
Latest FDA report on drug shortages: Can the economics be changed?
Task force report highlights the economic disincentives of short-supply products
DSCSA governance organization appears to be a go
New group will coordinate end-to-end supply chain practices in the US
QAS: An alternative to VAWD for drug wholesaler-distributors
Upstart organization seeks to create another pathway for acceptance by regulators and pharmacy benefit managers
Global logistics provider AIT Worldwide garners GDP certification
Certification of its Itasca, IL central control tower
Surprise!/No surprise: FDA grants a one-year delay for the salable-returns requirement of DSCSA
Trading partners will have until November 2020 to get their IT systems into operation
FDA’s Ilisa Bernstein joins APhA as a senior executive
A critical time for carrying DSCSA forward
Addressing spill control as part of USP compliance
Provider offers absorbents to manage hazardous drug cleanup
PDSA helps bring along a DSCSA governance organization
Updated prospectus proposes membership rules, budget and leadership
Prospectus For Establishment of a DSCSA Governance Body
NABP adopts a new logo
A changed look but not a changed direction
Trump Administration opens the door to drug importation
HHS Azar announces a plan to make a plan, roughly in time to be a talking point in next year’s national election
Throwing some cold water on the feasibility of US drug importation
HDA Research Foundation highlights constraints and additional costs of reimportation
Trump administration caves on reforming drug rebate system
News follows court ruling against advertising retail drug prices
FDA enforcement actions have ‘plummeted’ under Trump administration, says Science
CDER activity is one of the few exceptions
FDA strives to tighten API repackaging operations
Cross-contamination and missing documentation are cited in warning letters
Healthwell Foundation opens a contact center for PAPs
Meanwhile, federal enforcement actions over improper patient assistance continue to arise
A Conversation with Greg Cathcart, Excellis Health Solutions
A Conversation with Ara Ohanian, Systech International
Book Review: Bottle of Lies
Investigative journalist Katherine Eban returns with an indictment of generic drug quality
Healthcare Distribution Alliance takes to the airwaves
Association will promote its members' value to the public via digital advertising and publishing
DEA slams drug distributor executives with felony charges over opioid distribution
Rochester Drug Cooperative’s former CEO, Laurence Doud, is arrested
Counterfeit pillmaker was operating in New Jersey, alleges NYC district attorney
Counterfeit Xanax (alprazolam), plus meth and other controlled substances, were sold on the dark web
Here come drug prices in TV ads
A final rule is still in the works at HHS, but some manufacturers are testing the inclusion of prices in TV ads